• Study on Frozen Shoulder: Evaluating the Effectiveness of Physiotherapy, Triamcinolone Acetonide, and Lidocaine in Improving Shoulder Function and Reducing Pain

    Recruiting

    3 1 1 1
    Investigated diseases:
    Norway
  • Study on Ravulizumab for Children with IgA Nephropathy (Ages 2-17)

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Spain
  • Study of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

    Recruiting

    3 1 1
    Investigated diseases:
    Austria Belgium Bulgaria Croatia France Germany +9
  • Study on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Finland Poland Slovakia
  • Study on the Effectiveness and Safety of IMVT-1402 for Adults with Graves’ Disease

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Belgium Germany Hungary Italy Poland Spain
  • Study to Find Treatments for Chronic Kidney Disease Using Finerenone in Patients with Standard Care

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Greece Spain
  • Study on the Effects of Atorvastatin in Patients with Moderate to Severe Bile Acid Diarrhea

    Recruiting

    3 1 1
    Investigated drugs:
    Denmark
  • Study on the Effectiveness and Safety of SAR441566 for Adults with Moderate-to-Severe Ulcerative Colitis

    Recruiting

    2 1
    Investigated diseases:
    Austria Belgium Bulgaria Croatia Czechia France +6
  • Study on Cemiplimab and Mitotane for Patients with Advanced Adrenocortical Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study on Early vs. Late Restart of Anticoagulation with Edoxaban, Apixaban, and Warfarin for Patients with Chronic Subdural Hematoma and Atrial Fibrillation

    Recruiting

    4 1 1 1
    Finland Sweden

powered by